Atossa Therapeutics, Inc. (ATOS) NASDAQ
5.70
-0.03(-0.52%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
5.70
-0.03(-0.52%)
Currency In USD
| Previous Close | 5.73 |
| Open | 5.56 |
| Day High | 5.76 |
| Day Low | 5.56 |
| 52-Week High | 19.35 |
| 52-Week Low | 3.76 |
| Volume | 42,104 |
| Average Volume | 120,861 |
| Market Cap | 49.09M |
| PE | -1.41 |
| EPS | -4.04 |
| Moving Average 50 Days | 4.97 |
| Moving Average 200 Days | 10.01 |
| Change | -0.03 |
Atos named a Leader in ISG Provider Lens™ 2025 for Cybersecurity – Services and Solutions in the United States
GlobeNewswire Inc.
Feb 27, 2026 4:13 PM GMT
Atos named a Leader in ISG Provider Lens™ 2025 for Cybersecurity – Services and Solutions in the United States Irving, Texas, USA – February 27, 2026 – Atos, a global leader in AI-powered digital transformation, today announced it has been named a L
Eviden-built JUPITER Supercomputer Hits Exascale Milestone According to the TOP500, a First in Europe
GlobeNewswire Inc.
Nov 17, 2025 9:19 PM GMT
Paris, France – November 17, 2025 – Eviden, the Atos Group product brand leading in advanced computing, announces today the rankings of its 58 Eviden-built systems1 in the TOP500 and Green500, official listings of the world’s most powerful and most e
Atossa Therapeutics Appoints CORE IR for Investor Relations, Shareholder Communications and Public Relations Services
GlobeNewswire Inc.
Sep 17, 2025 12:00 PM GMT
Engagement to enhance investor awareness, strengthen shareholder engagement, and broaden reach to target institutional and retail audiencesSEATTLE, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS; “Atossa” or the “Company